Data-processing equipment

Tender description

Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment, the technical requirements of these instruments include: — automated nucleic acid extraction, — high throughout next-generation sequencing, — Nucleic Acid Fragment Analysis, — Liquid Handler. Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes providers of automated nucleic acid extraction equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome. Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes provides of high throughout next-generation sequencing equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome. Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes providers of Nucleic Acid Fragment Analysis equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome. Queen’s University Belfast (“Queen’s”) seeks to engage with providers of Genomic Instruments for Queen’s Precision Medicine Centre of Excellence. At the moment this includes providers of liquid handler equipment. The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput genomics, digital pathology and big data analytics in a fully integrated fashion. The PMC aims to accelerate the translation of potentially relevant diagnostic, prognostic and therapeutic findings into clinically actionable information by applying state-of-the-art technology in a clinical laboratory environment. Our partnerships and collaborations with industry, academia and healthcare organisations maximises the potential to capitalise in the value of integrated clinical and biomarker information to improve patient’s outcome.